Ear Nose & Throat Journal · 2021 · 38 citations · 49 references
Veterinary MedicineInfectious DiseasesPathobiologyHost-pathogen InteractionsImmunopathologyInflammationAcute Respiratory Distress SyndromeInfectious Disease PathophysiologyRespiratory InfectionsRespiratory Infectious DiseasesViral InfectionsViral PathogenesisElectrophysiological Olfactory TestingOlfactory AnatomyOlfactory CortexOlfactory Epithelium DamageOlfactory Epithelium PathologyOlfactory Function AssessmentSars-cov-2 InfectionSevere Acute Respiratory Syndrome
OBJECTIVES: The pandemic has affected over 182 million coronavirus disease 2019 (COVID-19) cases worldwide. Accumulated evidence indicates that anosmia is one of the significant characteristics of COVID-19 with a high prevalence. However, many aspects of COVID-19-induced anosmia are still far from being fully understood. The purpose of this review is to summarize recent developments in COVID-19-induced anosmia to increase awareness of the condition. METHODS: A literature search was carried out using the PubMed, Embase, Web of Science, and Scopus. We reviewed the latest literature on COVID-19-induced anosmia, including mechanisms of pathogenesis, olfactory testing, anosmia as predictive tool, pathological examinations, imaging findings, affected factors, co-existing diseases, treatments, prognosis, hypothesis theories, and future directions. RESULTS: The possible pathogenesis of COVID-19-induced anosmia may involve inflammation of the olfactory clefts and damage to the olfactory epithelium or olfactory central nervous system by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The D614G spike variant may also play a role in the increased number of anosmia patients. Anosmia may also be an essential indicator of COVID-19 spread and an early indicator of the effectiveness of political decisions. The occurrence and development of COVID-19-induced anosmia may be influenced by smoking behaviors and underlying diseases such as type 2 diabetes, gastroesophageal disorders, and rhinitis. Most patients with COVID-19-induced anosmia can fully or partially recover their olfactory function for varying durations. COVID-19-induced anosmia can be treated with various approaches such as glucocorticoids and olfactory training. CONCLUSION: Anosmia is one of the main features of COVID-19 and the underlying disease of the patient may also influence its occurrence and development. The possible pathogenesis of COVID-19-induced anosmia is very complicated, which may involve inflammation of the olfactory clefts and damage to the olfactory epithelium or olfactory central nervous system.
49
Katarzyna Bilińska, Patrycja Jakubowska, Christopher S. von Bartheld et al. · ACS Chemical Neuroscience · 2020 · 448 citations · Full text
Bertrand Bryche, Audrey St Albin, Séverine Murri et al. · Brain Behavior and Immunity · 2020 · 320 citations · Full text
Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6
Angela Pia Cazzolla, Roberto Lovero, Lorenzo Lo Muzio et al. · ACS Chemical Neuroscience · 2020 · 186 citations · Full text